SuperworthUniversal Health Services UHS
- Market cap
- $11B
- PE
- 7.6×
- 10y median 13.6×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.6×
- EV/EBIT
- 7.7×
- Revenue, 12 months
- $18.1B
- +10% on a year ago
- Net margin
- 8.4%
- Free cash flow yield
- 7.7%
Universal Health Services trades at 7.6× trailing earnings, cheaper than 95% of the last ten years. Revenue was $18.1B over the last twelve months, up 10% on a year earlier with a 8% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.6B+7% | $3.7B+7% | $3.8B+11% | $3.9B+10% | $4B+11% | $4.1B+11% | $4.1B+7% | $4.3B+10% | $4.5B+13% | $4.5B+9% | $4.5B+10% | $4.6B+8% | |
| $285.4M+3% | $331.2M+27% | $388.8M+40% | $436.4M+56% | $384.2M+35% | $472.5M+43% | $454.8M+17% | $500.3M+15% | $521.7M+36% | $517.2M+10% | $502.9M+11% | $516.7M+3% | |
| Interest expense | $53.4M+50% | $53.6M+22% | $52.8M+4% | $48.9M+0% | $44.7M−16% | $39.7M−26% | $40.1M−24% | $35.4M−28% | $38.4M−14% | $42.2M+6% | $37.1M−7% | $39.9M+13% |
| Pre-tax income | $220.5M−6% | $281.1M+26% | $336.1M+57% | $382M+70% | $341.5M+55% | $438.3M+56% | $420.4M+25% | $473.4M+24% | $496.9M+46% | $581.4M+33% | $469.1M+12% | $479.1M+1% |
| $52.5M−9% | $61.5M+18% | $70.3M+36% | $87.7M+58% | $75.6M+44% | $101.3M+65% | $98.8M+41% | $110.8M+26% | $117.8M+56% | $133.6M+32% | $110.4M+12% | $114.5M+3% | |
| Net income | $167M−9% | $216.4M+24% | $261.8M+61% | $289.2M+69% | $258.7M+55% | $332.4M+54% | $316.7M+21% | $353.2M+22% | $373M+44% | $445.9M+34% | $348.7M+10% | $358.4M+2% |
| $2.40−4% | $3.15+30% | $3.82+68% | $4.26+76% | $3.80+58% | $4.96+58% | $4.80+26% | $5.43+28% | $5.86+54% | $7.06+42% | $5.65+18% | $5.98+10% | |
| 69.6M−5% | 68.6M−5% | 68.5M−4% | 67.9M−4% | 68.1M−2% | 67.1M−2% | 66M−4% | 65M−4% | 63.7M−7% | 63.2M−6% | 61.7M−7% | 59.9M−8% |
EPS, diluted: 7 periods, Q4 FY09 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 17 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Care Facilities nearest Universal Health Services' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| UHSUniversal Health Services | $11B | 7.6× | 13.6× | n/m | 0.6× | +10% | 8.4% |
| DVADavita | $11.7B | 15.0× | 16.1× | n/m | 0.8× | +6% | 6.0% |
| ENSGEnsign | $10.2B | 27.5× | 25.5× | n/m | 1.9× | +19% | 6.9% |
| BTSGBrightSpring Health Services | $11.9B | 36.4× | 57.7× | n/m | 0.8× | +26% | 2.5% |
| EHCEncompass Health | $12.2B | 20.2× | 18.4× | n/m | 2.0× | +9% | 10.0% |
| PACSPACS | $7.5B | 27.2× | 27.2× | n/m | 1.4× | +15% | 4.8% |
| CHEChemed | $6.7B | 25.8× | 29.0× | n/m | 2.6× | +3% | 10.6% |
| THCTenet Healthcare | $21.6B | 10.4× | 11.2× | 12.9× | 1.0× | +5% | 10.3% |
| SHCSotera Health | $5.2B | 31.8× | 55.4× | n/m | 4.2× | +8% | 13.4% |
| CONConcentra Group Holdings Parent | $5B | 25.5× | 17.5× | n/m | 2.2× | +14% | 8.7% |
| LFSTLifeStance Health | $4.9B | 99.5× | 142× | n/m | 3.1× | +20% | 3.2% |
| Peer median | $8.9B | 26.5× | 26.3× | 12.9× | 1.9× | +12% | 7.8% |
More on Universal Health Services
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #6of 168Healthcare stocks with the lowest PE ratio
- #1of 25Hospital and care facility stocks with the lowest PE ratio
- #7of 92Healthcare stocks cheapest against their own PE history
- #4of 31Hospital and care facility stocks with the lowest EV/EBIT
- #2of 11Hospital and care facility stocks cheapest against their own PE history
- #9of 45Hospital and care facility stocks with the lowest price to sales ratio
- #10of 21Hospital and care facility stocks with the fastest earnings growth
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .